Literature DB >> 12006706

Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.

Matthias M Weber1, Christopher J Auernhammer, Phillip D K Lee, Dieter Engelhardt, Reinhart Zachoval.   

Abstract

INTRODUCTION: The liver is the main source of serum insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) and the concentration of these proteins might reflect liver function.
METHODS: In a retrospective longitudinal study we examined serum levels of total and free IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 in 21 adult patients with end-stage liver disease before and after orthotopic liver transplantation (LTX) by sensitive and specific RIAs. In each patient, the mean value of at least three measurements before and after LTX was calculated.
RESULTS: Before LTX, serum levels of total and free IGF-I, IGF-II, IGFBP-3 were low and showed a rapid and significant increase in almost all patients after successful LTX (total IGF-I: 30 +/- 7 vs. 256 +/- 30 ng/ml, p < 0.001; free IGF-I: 1.3 +/- 0.3 vs. 3.5 +/- 0.6 ng/ml, p < 0.01; IGF-II: 177 +/- 28 vs. 618 +/- 30 ng/ml, p < 0.001; IGFBP-3: 1,230 +/- 136 vs. 3,665 +/- 264 ng/ml, p < 0.001). In contrast, IGFBP-1 was found to be high immediately before LTX, and declined to normal levels after LTX (210 +/- 40 vs. 90 +/- 15 ng/ml, p < 0.01), while IGFBP-2 did not show any significant changes (1,154 +/- 296 vs. 1,303 +/- 192 ng/ ml). Positive correlations were found between IGF-I, IGF-II or IGFBP-3, and serum pseudocholinesterase (R = 0.50, 0.72 and 0.61 respectively, p < 0.001). Negative correlations were found between IGF-I, IGF-II or IGFBP-3, and prothrombin time (R = 0.50, 0.59 and 0.51 respectively, p < 0.001).
CONCLUSION: Patients with severe liver disease show decreased levels of total and free IGF-I, IGF-II and IGFBP-3, and increased levels of IGFBP-1. These abnormalities are promptly normalized after successful LTX. Thus, serum levels of IGF-I, IGF-II and IGFBP-3 might be useful parameters for the assessment of liver function. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006706     DOI: 10.1159/000057960

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

1.  Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation.

Authors:  Daniele Nicolini; Federico Mocchegiani; Gioia Palmonella; Martina Coletta; Marina Brugia; Roberto Montalti; Giammarco Fava; Augusto Taccaliti; Andrea Risaliti; Marco Vivarelli
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 2.  The risks of overlooking the diagnosis of secreting pituitary adenomas.

Authors:  Thierry Brue; Frederic Castinetti
Journal:  Orphanet J Rare Dis       Date:  2016-10-06       Impact factor: 4.123

Review 3.  Insulin-Like Growth Factor (IGF) System in Liver Diseases.

Authors:  Agnieszka Adamek; Aldona Kasprzak
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

4.  Deciphering short stature in children.

Authors:  Nella Polidori; Valeria Castorani; Angelika Mohn; Francesco Chiarelli
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

5.  Relationship between GH/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation.

Authors:  Angela Salso; Giuseppe Tisone; Laura Tariciotti; Ilaria Lenci; Tommaso Maria Manzia; Leonardo Baiocchi
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

Review 6.  The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders.

Authors:  Werner F Blum; Abdullah Alherbish; Afaf Alsagheir; Ahmed El Awwa; Walid Kaplan; Ekaterina Koledova; Martin O Savage
Journal:  Endocr Connect       Date:  2018-05-03       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.